Cadila Pharma Begins Work On $150 Million Production Plant In Russia
This article was originally published in PharmAsia News
Executive Summary
Cadila Pharmaceutical has begun construction on a $150 million plant in Russia it plans to use as part of its expansion into the major emerging markets, which also includes Africa and China.